Three more Hall voters accuse Jeff Bagwell of being a juicer

89 Comments

Via The Platoon Advantage, we come across three more Hall of Fame voters, all from Chicago, who have determined based on either (a) nothing; or (b) rumor or information that they posses but don’t feel is up to the standards of being published in a piece of ethical journalism,* that Jeff Bagwell did steroids and thus isn’t worthy of the Hall of Fame. They are Philip Hersh and Paul Sullivan of the  Chicago Tribune and Scot Gregor of the Daily Herald.

Hersh says “I’m still too suspicious about Jeff Bagwell to include him.”  Sullivan lumps Bagwell in with the “unindicted but suspected contributors to the PED mess.”  Gregor says “[s]uspicions of using “performance enhancing drugs” weigh heavily on my decision to leave off productive players such as Bagwell, Mark McGwire, Rafael Palmeiro and Juan Gonzalez.”

Hey, their ballots. They can use ’em how they want to. I just hope for their sake no one judges their careers’ worth in such a fashion, because it’s totally harsh and unfair and I’d hate for them to have to go through that.

Anyway, if that makes you feel all icky, go read Posnanski’s take on such Hall of Fame votes in historical context. I think he hits it on the head when he talks about how these guys see themselves as something more than mere assessors of baseball performance and something more like gatekeepers with an inflated sense of their place in the process.

But hey, at least they’re keeping us and history all safe from, well, something.

 

*Hopefully this point is not considered controversial. Because it’s nothing more than simple logic. By definition, people either have actual information establishing that Bagwell did steroids or they do not.  If they do have it, they have not published it. And given how newsworthy such information would be, the only plausible reason they haven’t published it is because their newspapers would not allow them to do it because the information is thin and/or uncorroborated. So: such a stance as the one shown by these gentleman is necessarily either one taken with no information or with information that falls short of the standards to which they usually adhere in their daily work.

Phillies, Red Sox interested in Carlos Santana

Getty Images
5 Comments

The Phillies and Red Sox appear intent on pursuing free agent first baseman Carlos Santana, MLB Network’s Jon Morosi reports. Santana rejected a one-year, $17.4 million qualifying offer from the Indians on Thursday and is expected to draw widespread interest on the market this winter. The Mets, Mariners, Angels and Indians could make a play for the infielder, though no serious offers have been made this early in the offseason.

Santana, 31, is coming off of a seven-year track with the Indians. He batted .259/.363/.455 with 23 home runs and 3.0 fWAR last season, making 2017 the fourth-most valuable year of his career to date. Although he was primarily stationed at first base over the last year, he could step back into a hybrid first base/DH role with the Red Sox, who are hurting for infield depth with Hanley Ramirez still working his way back from shoulder surgery.

As for Santana’s other suitors, the Mariners are far less likely to pursue a deal after trading for Ryon Healy last Wednesday. Neither the Mets nor the Phillies have a DH spot to offer the veteran infielder, and the Phillies’ Rhys Hoskins appears to be blocking the way at first base. Then again, Santana may not find a more enticing offer outside of Cleveland, where Edwin Encarnacion might otherwise be the club’s best option at first base. During the GM meetings, Indians’ GM Mike Chernoff said he “love to have both [Santana and Jay Bruce] back” in 2018, but hasn’t backed up that love with any contract talks just yet.